New York to require social media platforms to display mental health warnings
Dec 26 (Reuters) – Social media platforms with infinite scrolling, auto-play and algorithmic feeds will be required to…
Hedge funds short healthcare providers as subsidies debate intensifies
LONDON, Dec 22 (Reuters) – Hedge funds last week sold more U.S. healthcare stocks than they bought for…
Obamacare enrollment declines as US subsidies expire
WASHINGTON, Dec 23 (Reuters) – Enrollment for health insurance under the U.S. Affordable Care Act dipped to 15.6…
Fortis Healthcare to acquire Bengaluru’s People Tree Hospital for 4.3 billion rupees
Dec 20 (Reuters) – India’s Fortis Healthcare (FOHE.NS), opens new tab said on Saturday it will acquire People…
Trump said he has no bigger healthcare plans: Obamacare will ‘repeal itself’
“I don’t have to do anything,” Trump tells NBC Trump says ACA will be ‘too expensive’ to use…
Medicare enrollees to pay 50% less for some drugs in 2025, report says
AARP study looks at first 10 drugs negotiated under IRA Finds 7 of the drugs will cost under…
Americans facing soaring health insurance costs may get a lifeline in 2026, experts say
Political pressure to prompt Obamacare credit extension, investors say Enrollment period may extend if subsidies are retroactively enacted,…
FDA approves BioCryst’s oral pellet version of swelling disorder drug for children
Dec 12 (Reuters) – The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst…
US FDA approves first at-home device for depression
Dec 11 (Reuters) – The U.S. Food and Drug Administration has approved Flow Neuroscience’s at-home brain stimulation device…
UK pledges extra $2 billion NHS spend to avert Trump tariffs, FT says
Dec 11 (Reuters) – Britain has promised the United States that spending on National Health Service (NHS) medicines…
UK medicine rebate rate to drop in 2026 after US pharma deal
Item 1 of 2 Unused and expired medications, including pills, tablets and capsules, collected for disposal to prevent…
US FDA qualifies first AI tool to help speed liver disease drug development
Dec 8 (Reuters) – The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed…